A new laser treatment for localised prostate cancer has produced encouraging early results at Guy’s Hospital in Southwark, in what the NHS says is the technology’s first use in a European hospital.
The hospital is running a pilot involving 30 patients. Among the first 10 treated with ProFocal laser therapy, eight had their cancer completely eradicated in the treated area, while two had only a minimal amount remaining.
A focused treatment with same-day recovery
The procedure uses MRI and ultrasound imaging to guide a fine laser fibre into the tumour through the perineum. Laser energy is then delivered directly into the cancerous area through a cooled metal rod.
It takes about an hour and is carried out under a light general anaesthetic, allowing patients to return home the same day. The approach is designed to treat different parts of the prostate while preserving as much healthy tissue and function as possible.
The early findings are not yet a guarantee of long-term success. Patients will have regular follow-ups, including an MRI after one year, to assess how durable the results are. The pilot is intended to replicate an Australian study involving more than 100 patients.
The treatment system was bought with a £125,000 donation from the London Freemasons, administered through Guy’s Cancer Charity. Its wider UK availability will depend on further testing and regulatory approval.
Why it matters for Britain
The pilot gives NHS clinicians valuable evidence on a potentially less invasive option for some prostate cancer patients. Same-day treatment and reduced side effects could also support recovery and patient quality of life if longer-term results remain positive.
